Bo Yu

2.7k total citations · 1 hit paper
111 papers, 1.7k citations indexed

About

Bo Yu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Bo Yu has authored 111 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 36 papers in Pulmonary and Respiratory Medicine and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Bo Yu's work include Lung Cancer Treatments and Mutations (10 papers), Renal cell carcinoma treatment (7 papers) and Aortic Disease and Treatment Approaches (7 papers). Bo Yu is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Renal cell carcinoma treatment (7 papers) and Aortic Disease and Treatment Approaches (7 papers). Bo Yu collaborates with scholars based in China, United States and Sweden. Bo Yu's co-authors include Qiu Rao, Xiaojun Zhou, Qiuyuan Xia, Qun-Li Shi, Biao Liu, Qiong Du, Qing Zhai, Weihao Shi, Zhenfeng Lu and Rusong Zhang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Bo Yu

104 papers receiving 1.7k citations

Hit Papers

Using Cu‐Based Metal–Organic Framework as a Comprehensive... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Yu China 23 800 391 367 314 194 111 1.7k
Chiara Mignogna Italy 26 500 0.6× 290 0.7× 340 0.9× 252 0.8× 183 0.9× 96 1.7k
Guoping Wang China 24 977 1.2× 280 0.7× 419 1.1× 361 1.1× 100 0.5× 87 1.9k
Xinxin Zhang China 18 684 0.9× 436 1.1× 517 1.4× 318 1.0× 156 0.8× 76 1.5k
Shotaro Naito Japan 24 896 1.1× 456 1.2× 547 1.5× 370 1.2× 79 0.4× 82 2.1k
Tao Yin China 24 706 0.9× 189 0.5× 258 0.7× 233 0.7× 152 0.8× 70 1.7k
Heyu Zhang China 25 868 1.1× 191 0.5× 325 0.9× 296 0.9× 103 0.5× 88 1.8k
Hongmei Gu China 28 964 1.2× 293 0.7× 362 1.0× 279 0.9× 148 0.8× 96 2.3k
Yan Yao China 21 793 1.0× 174 0.4× 257 0.7× 411 1.3× 242 1.2× 77 1.6k
Jiahai Shi China 21 977 1.2× 230 0.6× 159 0.4× 479 1.5× 252 1.3× 91 1.7k
Min Suk Kim South Korea 30 624 0.8× 731 1.9× 416 1.1× 435 1.4× 260 1.3× 97 2.2k

Countries citing papers authored by Bo Yu

Since Specialization
Citations

This map shows the geographic impact of Bo Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Yu more than expected).

Fields of papers citing papers by Bo Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Yu. The network helps show where Bo Yu may publish in the future.

Co-authorship network of co-authors of Bo Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Yu. A scholar is included among the top collaborators of Bo Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Yu. Bo Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Dongxu, Yang Chen, Han Wang, et al.. (2025). High perioperative lactate levels as a potential predictor for severe acute kidney injury following aortic arch surgery. Frontiers in Medicine. 11. 1495502–1495502. 1 indexed citations
2.
Lu, Zhao‐Yang, Qing Chai, Wenbin Dai, et al.. (2025). Mitochondrial homeostasis restoring peptide-drug conjugates with ROS-responsive NO releasing ability for targeted therapy of myocardial infarction. Journal of Nanobiotechnology. 23(1). 496–496. 3 indexed citations
3.
Hong, Quan, Zhong‐Xun Liu, Haifeng Liang, et al.. (2024). Inhibition of HOXD11 promotes cartilage degradation and induces osteoarthritis development. Journal of Orthopaedic Surgery and Research. 19(1). 111–111. 2 indexed citations
4.
Huang, Lei, Fanfan Zhao, Muye He, et al.. (2024). An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants. Journal of Controlled Release. 366. 479–493. 12 indexed citations
5.
Li, Fengfeng, et al.. (2024). A nomogram with Ki-67 in the prediction of postoperative recurrence and death for glioma. Scientific Reports. 14(1). 20334–20334. 3 indexed citations
6.
Yu, Bo, Jun‐Tao Lin, Chaoyu Fan, et al.. (2024). Using Cu‐Based Metal–Organic Framework as a Comprehensive and Powerful Antioxidant Nanozyme for Efficient Osteoarthritis Treatment. Advanced Science. 11(13). e2307798–e2307798. 83 indexed citations breakdown →
7.
Tan, Jinyun, Yang Zhou, Qing‐Yu He, et al.. (2023). Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events. Arteriosclerosis Thrombosis and Vascular Biology. 43(12). 2312–2332. 13 indexed citations
8.
Zhang, Jia, Zuozhen Yang, Fan Yang, et al.. (2021). A splicing variation in NPRL2 causing familial focal epilepsy with variable foci: additional cases and literature review. Journal of Human Genetics. 67(2). 79–85. 7 indexed citations
9.
Du, Qiong, Xuan Ye, Huan Li, et al.. (2021). Exosomal miR-30a and miR-222 derived from colon cancer mesenchymal stem cells promote the tumorigenicity of colon cancer through targeting MIA3. Journal of Gastrointestinal Oncology. 12(1). 52–68. 39 indexed citations
10.
Yu, Bo, et al.. (2020). Study on Attribute and Trust-Based RBAC Model in Cloud Computing. Computer Engineering and Applications Journal. 56(9). 84–92. 4 indexed citations
12.
Sun, Yang, Chenze Li, Lína Zhang, et al.. (2019). Clinical outcomes after ticagrelor and clopidogrel in Chinese post-stented patients. Atherosclerosis. 290. 52–58. 19 indexed citations
13.
Chen, Demeng, Man-Si Wu, Li Yang, et al.. (2017). Targeting BMI1 + Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma. Cell stem cell. 20(5). 621–634.e6. 222 indexed citations
14.
Zhang, Xueying, Bo Yu, Yuan‐Zhe Jin, et al.. (2015). A study of IgG antibodies to the ApoB protein in non-ST segment elevation acute coronary syndrome. Scandinavian Cardiovascular Journal. 49(3). 136–141. 2 indexed citations
15.
Rao, Qiu, Biao Liu, Liang Cheng, et al.. (2012). Renal Cell Carcinomas With t(6;11)(p21;q12). The American Journal of Surgical Pathology. 36(9). 1327–1338. 60 indexed citations
16.
Yu, Bo. (2011). Investigation of Bristol Chronic Obstructive Pulmonary Disease Knowledge Questionnaire for Rehabilitation Professionals. Zhongguo kangfu lilun yu shijian. 1 indexed citations
17.
Ba, Yue, Yuejin Yang, Bo Yu, et al.. (2010). Serum calciotropic hormone levels, and dental fluorisis in children exposed to different concentrations of fluoride and iodine in drinking water. Chinese Medical Journal. 123(6). 675–679. 13 indexed citations
18.
He, Lifeng, et al.. (2009). Inactivity kinetics for quality-related enzymes in vegetable with high-temperature short-time treatment.. Nongye gongcheng xuebao. 25(9). 339–344. 1 indexed citations
19.
Yu, Bo. (2006). Overview of Gird Workflow. Jisuanji gongcheng. 1 indexed citations
20.
Abdelmoez, Walid, et al.. (2004). Error propagation in software architectures. 384–393. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026